Log In Home    Contact

Achieving the Vision

Any institution or individual involved in HIV vaccine research, policy, funding, and advocacy can contribute to achieving the goals of the Enterprise. Specific ways to contribute include:

Scientists and research organizations:

  • Participate in research to address priorities in the Enterprise scientific plan
  • Increase collaboration and sharing of data and research protocols

Government and philanthropic funding agencies:

  • Increase funding for HIV vaccine research
  • Target funding to projects that support priorities in the Enterprise scientific plan

Political leaders:

  • Vocally support increased, more collaborative HIV vaccine research
  • Host clinical trials in developing countries, where an HIV vaccine is needed most
  • Adopt policies to support HIV vaccine research, such as incentives for increased private sector investment

Pharmaceutical and biotechnology companies:

  • Be actively engaged in HIV vaccine research; increase investments and target resources to support the priority areas of the Enterprise scientific plan
  • Provide technical expertise to build capacity for HIV vaccine development and manufacturing
  • Collaborate with all stakeholders to ensure that intellectual property concerns are addressed in order to accelerate vaccine development

Community leaders, advocates, and nongovernmental organizations:

  • Advocate on behalf of HIV vaccine research and the priorities in the Enterprise scientific plan as part of a comprehensive response to the epidemic
  • Promote meaningful community engagement in vaccine research by broadening research awareness and encouraging participation in community advisory boards at clinical trial sites
  • Work with the media to ensure communities are informed regarding HIV vaccine research progress, priorities, and activities
pull quote

© 2005 Global HIV Vaccine Enterprise Privacy Policy    Terms & Conditions    View Enterprise Brochure